These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 11358334)
1. Low affinity of beta1-adrenergic receptor for beta-arrestins explains the resistance to agonist-induced internalization. Shiina T; Nagao T; Kurose H Life Sci; 2001 Apr; 68(19-20):2251-7. PubMed ID: 11358334 [TBL] [Abstract][Full Text] [Related]
2. Interaction with beta-arrestin determines the difference in internalization behavor between beta1- and beta2-adrenergic receptors. Shiina T; Kawasaki A; Nagao T; Kurose H J Biol Chem; 2000 Sep; 275(37):29082-90. PubMed ID: 10862778 [TBL] [Abstract][Full Text] [Related]
3. Role of the G protein-coupled receptor kinase site serine cluster in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation. Vaughan DJ; Millman EE; Godines V; Friedman J; Tran TM; Dai W; Knoll BJ; Clark RB; Moore RH J Biol Chem; 2006 Mar; 281(11):7684-92. PubMed ID: 16407241 [TBL] [Abstract][Full Text] [Related]
4. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323 [TBL] [Abstract][Full Text] [Related]
6. Beta-arrestin2 enhances beta2-adrenergic receptor-mediated nuclear translocation of ERK. Kobayashi H; Narita Y; Nishida M; Kurose H Cell Signal; 2005 Oct; 17(10):1248-53. PubMed ID: 16038799 [TBL] [Abstract][Full Text] [Related]
7. Visualizing differences in ligand-induced beta-arrestin-GFP interactions and trafficking between three recently characterized G protein-coupled receptors. Evans NA; Groarke DA; Warrack J; Greenwood CJ; Dodgson K; Milligan G; Wilson S J Neurochem; 2001 Apr; 77(2):476-85. PubMed ID: 11299310 [TBL] [Abstract][Full Text] [Related]
8. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors. Anborgh PH; Seachrist JL; Dale LB; Ferguson SS Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533 [TBL] [Abstract][Full Text] [Related]
9. Resistance of the human beta1-adrenergic receptor to agonist-induced ubiquitination: a mechanism for impaired receptor degradation. Liang W; Fishman PH J Biol Chem; 2004 Nov; 279(45):46882-9. PubMed ID: 15331590 [TBL] [Abstract][Full Text] [Related]
10. Visualization of agonist-induced association and trafficking of green fluorescent protein-tagged forms of both beta-arrestin-1 and the thyrotropin-releasing hormone receptor-1. Groarke DA; Wilson S; Krasel C; Milligan G J Biol Chem; 1999 Aug; 274(33):23263-9. PubMed ID: 10438501 [TBL] [Abstract][Full Text] [Related]
12. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*. Oakley RH; Laporte SA; Holt JA; Barak LS; Caron MG J Biol Chem; 2001 Jun; 276(22):19452-60. PubMed ID: 11279203 [TBL] [Abstract][Full Text] [Related]
13. Agonist-induced endocytosis and recycling of the gonadotropin-releasing hormone receptor: effect of beta-arrestin on internalization kinetics. Vrecl M; Anderson L; Hanyaloglu A; McGregor AM; Groarke AD; Milligan G; Taylor PL; Eidne KA Mol Endocrinol; 1998 Dec; 12(12):1818-29. PubMed ID: 9849957 [TBL] [Abstract][Full Text] [Related]
14. A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types. Zhang J; Barak LS; Winkler KE; Caron MG; Ferguson SS J Biol Chem; 1997 Oct; 272(43):27005-14. PubMed ID: 9341139 [TBL] [Abstract][Full Text] [Related]
16. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Azzi M; Charest PG; Angers S; Rousseau G; Kohout T; Bouvier M; Piñeyro G Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11406-11. PubMed ID: 13679574 [TBL] [Abstract][Full Text] [Related]
17. Similarities and differences in the coupling of human beta1- and beta2-adrenoceptors to Gs(alpha) splice variants. Wenzel-Seifert K; Liu HY; Seifert R Biochem Pharmacol; 2002 Jul; 64(1):9-20. PubMed ID: 12106601 [TBL] [Abstract][Full Text] [Related]
18. Identification of a β-arrestin-biased negative allosteric modulator for the β Ippolito M; De Pascali F; Hopfinger N; Komolov KE; Laurinavichyute D; Reddy PAN; Sakkal LA; Rajkowski KZ; Nayak AP; Lee J; Lee J; Cao G; Donover PS; Reichman M; An SS; Salvino JM; Penn RB; Armen RS; Scott CP; Benovic JL Proc Natl Acad Sci U S A; 2023 Aug; 120(31):e2302668120. PubMed ID: 37490535 [TBL] [Abstract][Full Text] [Related]
19. Interaction of arrestins with intracellular domains of muscarinic and alpha2-adrenergic receptors. Wu G; Krupnick JG; Benovic JL; Lanier SM J Biol Chem; 1997 Jul; 272(28):17836-42. PubMed ID: 9211939 [TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of the delta-opioid receptor regulates its beta-arrestins selectivity and subsequent receptor internalization and adenylyl cyclase desensitization. Qiu Y; Loh HH; Law PY J Biol Chem; 2007 Aug; 282(31):22315-23. PubMed ID: 17565992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]